The Melanoma Nursing Initiative – Home › Forums › Immunotherapy › Reimbursement › Nivolumab dosing and Medicare › Reply To: Nivolumab dosing and Medicare
July 18, 2018 at 1:57 pm #4866
Expert NurseLisa Kottschade
Just an update! I’m sure most of us got the memo, but 480 mg dosing is now approved for medicare. I do belive there is a 28 day stipulation on there, so may need to be a little more careful with scheduling.